Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Submitted by
admin
on March 3, 2017 - 9:24am
Source:
Endpoints
News Tags:
Sanofi
AstraZeneca
RSV
MEDI8897
Headline:
Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Do Not Allow Advertisers to Use My Personal information
